N-(3-BROMO-1-METHYL-1H-INDAZOL-6-YL)ACETAMIDE, 95.0%, 1g

TERT-BUTYL 3-(BENZYLAMINO)-3-(2-ETHOXY-2-OXOETHYL)AZETIDINE-1-CARBOXYLATE, 95.0%, 5g

Methyl 4-((1h-imidazol-1-yl)methyl)benzoate, 98%, 1g

2-(6-BROMO-3-INDOLYL)-2-OXOACETIC ACID, 95%, 1g

Hyaluronate Octasaccharide>95.0%(HPLC)1mg

2-(Benzyloxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(2-methoxyphenyl)acetic acid, 98+%, 1g

4-Heptylbenzonitrile>98.0%(GC)1mL

tert-Butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate, 95.0%, 1g

Tapón con labio abatible, Adecuado para, NS 12/21, 12,7, 12,3 mm, 50 Unidad(es)

o-Tolyl-methanesulfonyl chloride, 95.0%, 1g

BENZYL (6-CHLORO-5-FLUOROPYRIDIN-3-YL)CARBAMATE, 90.0%, 2g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3-(trifluoromethyl)phenyl)butanoic acid, 96%, 250mg